Moreover, the PD-L1/PD-1 interaction has also been shown to boost glycolysis in cancer cells while inhibiting it in T cells, providing cancer cells with a metabolic advantage in the nutrient-poor tumor microenvironment [48]. Here, CD274 is linked to neoplasm.